CAMG Solamere Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.61M | Buy |
|
|||||
|
2021
Q2 | $1.39M | Sell |
|
|||||
|
2021
Q1 | $1.32M | Sell |
|
|||||
|
2020
Q4 | $1.34M | Sell |
|
|||||
|
2020
Q3 | $1.93M | Sell |
|
|||||
|
2020
Q2 | $2M | Sell |
|
|||||
|
2020
Q1 | $3.29M | Sell |
|
|||||
|
2019
Q4 | $5.27M | Buy |
|
|||||
|
2019
Q3 | $3.98M | Sell |
|
|||||
|
2019
Q2 | $3.9M | Buy |
|
|||||
|
2019
Q1 | $3.34M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $336K | Sell |
|
|||||
|
2018
Q2 | $488K | Sell |
|
|||||
|
2018
Q1 | $843K | Sell |
|
|||||
|
2017
Q4 | $962K | Buy |
|
|||||
|
2017
Q3 | $885K | Buy |
|
|||||
|
2017
Q2 | $730K | Buy |
|
|||||
|
2017
Q1 | $682K | Buy |
|
|||||
|
2016
Q4 | $733K | Buy |
|